Gilead Sciences buying Kite Pharma for $11.9 billion

Gilead Sciences is buying Kite Pharma for $11.9 billion, gaining cell therapies for cancer. The deal is targeted to close in the 4th quarter.

from ABC News: Health http://ift.tt/2whW5Et
via HEALTH